| Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer A Sawant, J Deshane, J Jules, CM Lee, BA Harris, X Feng, ... Cancer research 73 (2), 672-682, 2013 | 179 | 2013 |
| Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells A Sawant, JA Hensel, D Chanda, BA Harris, GP Siegal, A Maheshwari, ... The Journal of Immunology 189 (9), 4258-4265, 2012 | 178 | 2012 |
| Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations T Ge, MR Irvin, A Patki, V Srinivasasainagendra, YF Lin, HK Tiwari, ... Genome medicine 14 (1), 70, 2022 | 56 | 2022 |
| Returning integrated genomic risk and clinical recommendations: The eMERGE study JE Linder, A Allworth, HT Bland, PJ Caraballo, RL Chisholm, EW Clayton, ... Genetics in Medicine 25 (4), 100006, 2023 | 40 | 2023 |
| Prostate cancer‐derived cathelicidin‐related antimicrobial peptide facilitates macrophage differentiation and polarization of immature myeloid progenitors to protumorigenic … HR Cha, JH Lee, JA Hensel, AB Sawant, BH Davis, CM Lee, JS Deshane, ... The Prostate 76 (7), 624-636, 2016 | 40 | 2016 |
| Prescribing prevalence of medications with potential genotype-guided dosing in pediatric patients LB Ramsey, HH Ong, JS Schildcrout, Y Shi, LA Tang, JK Hicks, ... JAMA network open 3 (12), e2029411-e2029411, 2020 | 39 | 2020 |
| Opportunity for genotype‐guided prescribing among adult patients in 11 US health systems JK Hicks, N El Rouby, HH Ong, JS Schildcrout, LB Ramsey, Y Shi, ... Clinical Pharmacology & Therapeutics 110 (1), 179-188, 2021 | 35 | 2021 |
| Pharmacogenetic predictors of cannabidiol response and tolerability in treatment‐resistant epilepsy BH Davis, TM Beasley, M Amaral, JP Szaflarski, T Gaston, ... Clinical Pharmacology & Therapeutics 110 (5), 1368-1380, 2021 | 27 | 2021 |
| Translational pharmacogenomics: discovery, evidence synthesis and delivery of race‐conscious medicine BH Davis, NA Limdi Clinical Pharmacology & Therapeutics 110 (4), 909-925, 2021 | 21 | 2021 |
| Validation of the Spartan RXCYP2C19 Genotyping Assay Utilizing Blood Samples BH Davis, G DeFrank, NA Limdi, S Harada Clinical and Translational Science 13 (2), 260-264, 2020 | 8 | 2020 |
| Personalizing direct oral anticoagulant therapy for a diverse population: Role of race, kidney function, drug interactions, and pharmacogenetics LE Thompson, BH Davis, R Narayan, B Goff, TM Brown, NA Limdi Clinical Pharmacology & Therapeutics 113 (3), 585-599, 2023 | 6 | 2023 |
| Evaluation of population‐level pharmacogenetic actionability in Alabama BH Davis, K Williams, D Absher, B Korf, NA Limdi Clinical and Translational Science 14 (6), 2327-2338, 2021 | 5 | 2021 |
| Validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations T Ge, A Patki, V Srinivasasainagendra, YF Lin, MR Irvin, HK Tiwari, ... medRxiv, 2021.09. 11.21263413, 2021 | 4 | 2021 |
| Improvement in kidney function after ventricular assist device implantation and its influence on thromboembolism, hemorrhage, and mortality BH Davis, AK Boehme, SV Pamboukian, M Allon, JF George, C Dillon, ... ASAIO Journal 66 (3), 268-276, 2020 | 2 | 2020 |
| 338 The Alabama Genomic Health Initiative: Integrating Genomic Medicine into Primary Care NA Limdi, D Absher, I Asif, L Bateman, G Barsh, KM Bowling, GM Cooper, ... Journal of Clinical and Translational Science 7 (s1), 100-101, 2023 | 1 | 2023 |
| Risk factors for major hemorrhage among patients receiving dabigatran across the Spectrum of CKD not requiring dialysis therapy BH Davis, R Sangha, C Dillon, TM Brown, R Narayan, M Beasley, ... American journal of kidney diseases: the official journal of the National …, 2021 | 1 | 2021 |
| Between a rock and a hard place: a high-risk patient with resistance to multiple P2Y12 antagonists BH Davis, C Dillon, A Cai, LA Williams III, SV Pamboukian, NA Limdi Pharmacogenomics 20 (7), 475-481, 2019 | 1 | 2019 |
| Polygenic Risk for Type 2 Diabetes in African Americans MR Irvin, T Ge, A Patki, V Srinivasasainagendra, ND Armstrong, B Davis, ... Diabetes, db230232, 2024 | | 2024 |
| EP04. 05-03 Perspectives of Potentially Eligible Indigenous Māori on a Lung Cancer Screening Programme-A Qualitative Study K Parker, K Bartholomew, B Davis, D Enoka, S Colhoun, A Maxwell, ... Journal of Thoracic Oncology 18 (11), S465, 2023 | | 2023 |
| P1. 18-05 Te Oranga Pūkahukahu: Developing an Indigenous Māori Led Approach to Lung Cancer Screening K Parker, K Bartholomew, T Schaapveld, G Steel, A Fraser, B Davis, ... Journal of Thoracic Oncology 18 (11), S228, 2023 | | 2023 |
